MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1039/d5tb00468c

Медицинская библиотека · Journal of materials chemistry. B · 2025

Efficacy and hepatotoxicity of tamoxifen-loaded fructose-based nanodrug for breast cancer treatment.

Fan Mingliang, Zheng Jiayu, Huang Yue, Lu Hongxu, Lu Mingxia

СтатьяПеревод пока не подготовлен

Аннотация

Breast cancer is one of the most harmful diseases affecting human health. Low drug accumulation at the tumor site and the severe side effects of traditional chemotherapeutics compromise their effectiveness in breast cancer treatment. Utilizing nanocarriers for targeted delivery and controlled release of therapeutics to cancer cells could be a promising pathway to alleviate these problems. Herein, we synthesized a novel prodrug conjugate coupling hydrophilic fructooligosaccharide with hydrophobic tamoxifen via a reactive oxygen species (ROS)-responsive aryl boronic ester linker, these amphiphilic conjugates could self-assemble into nanoparticles with high drug loading capacity and realize not only active breast cancer targeting via fructooligosaccharide moiety, but also controlled drug release through boronic ester bond breakage in higher ROS levels of the tumor cells. These nanoparticles showed specific cellular internalization and targeted cytotoxicity in MCF-7 breast cancer cells. To evaluate the hepatotoxicity of nanodrugs, a liver organoid model was established to simulate the in vivo metabolism of nanodrugs and assess their activities in the liver tissue. The results demonstrated that a low concentration (25 μg mL-1) of nanodrugs could inhibit cellular proliferation of breast cancer cells significantly without showing obvious toxicity to liver organoids, implicating a favorable efficacy and safety profile of these nanodrugs. Therefore, the tamoxifen-loaded fructose-based nanodrug might be a promising platform for improving tumor targeting and reducing side effects in breast cancer treatment.

Для цитирования: Fan Mingliang, Zheng Jiayu, Huang Yue, Lu Hongxu, Lu Mingxia. Efficacy and hepatotoxicity of tamoxifen-loaded fructose-based nanodrug for breast cancer treatment.. Journal of materials chemistry. B. 2025. DOI: 10.1039/d5tb00468c.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.